Click here to get full coverage on HC Wainwright & Co. Maintains Bionano Genomics (BNGO) Buy Recommendation - Nasdaq

HC Wainwright & Co. Maintains Bionano Genomics (BNGO) Buy Recommendation  Nasdaq

HC Wainwright & Co. Maintains Bionano Genomics (BNGO) Buy Recommendation - Nasdaq

Click here to get full coverage on Bionano Genomics (BNGO) Showcases Optical Genome Mapping Advances at AMP 2025 - GuruFocus

Bionano Genomics (BNGO) Showcases Optical Genome Mapping Advances at AMP 2025  GuruFocus

Bionano Genomics (BNGO) Showcases Optical Genome Mapping Advances at AMP 2025 - GuruFocus

Click here to get full coverage on Bionano Genomics Inc (BNGO) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Cost ... - Yahoo Finance

Bionano Genomics Inc (BNGO) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Cost ...  Yahoo Finance

Bionano Genomics Inc (BNGO) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Cost ... - Yahoo Finance

Click here to get full coverage on $30M Total Potential: Bionano Genomics Launches Strategic Public Offering with 5-Year Warrants - Stock Titan

$30M Total Potential: Bionano Genomics Launches Strategic Public Offering with 5-Year Warrants  Stock Titan

$30M Total Potential: Bionano Genomics Launches Strategic Public Offering with 5-Year Warrants - Stock Titan

Click here to get full coverage on Bionano Genomics Showcases Advancements in Optical Genome Mapping at AMP Annual Meeting 2025 - Quiver Quantitative

Bionano Genomics Showcases Advancements in Optical Genome Mapping at AMP Annual Meeting 2025  Quiver Quantitative

Bionano Genomics Showcases Advancements in Optical Genome Mapping at AMP Annual Meeting 2025 - Quiver Quantitative

Click here to get full coverage on H.C. Wainwright Maintains Bionano Genomics(BNGO.US) With Buy Rating, Cuts Target Price to $7 - 富途牛牛

H.C. Wainwright Maintains Bionano Genomics(BNGO.US) With Buy Rating, Cuts Target Price to $7  富途牛牛

H.C. Wainwright Maintains Bionano Genomics(BNGO.US) With Buy Rating, Cuts Target Price to $7 - 富途牛牛

Click here to get full coverage on BNGO: Revenue rose 21% and net loss narrowed, but going concern risk persists without new funding - TradingView — Track All Markets

BNGO: Revenue rose 21% and net loss narrowed, but going concern risk persists without new funding  TradingView — Track All Markets

BNGO: Revenue rose 21% and net loss narrowed, but going concern risk persists without new funding - TradingView — Track All Markets

Click here to get full coverage on Final 2026 Clinical Lab Fee Schedule Indicates a 47% - GlobeNewswire

Final 2026 Clinical Lab Fee Schedule Indicates a 47%  GlobeNewswire

Final 2026 Clinical Lab Fee Schedule Indicates a 47% - GlobeNewswire

Click here to get full coverage on Bionano Genomics (Nasdaq: BNGO) sets Nov. 13, 4:30 p.m. ET webcast to report results - Stock Titan

Bionano Genomics (Nasdaq: BNGO) sets Nov. 13, 4:30 p.m. ET webcast to report results  Stock Titan

Bionano Genomics (Nasdaq: BNGO) sets Nov. 13, 4:30 p.m. ET webcast to report results - Stock Titan

Click here to get full coverage on Despite Fast-paced Momentum, Bionano Genomics (BNGO) Is Still a Bargain Stock - Yahoo Finance

Despite Fast-paced Momentum, Bionano Genomics (BNGO) Is Still a Bargain Stock  Yahoo Finance

Despite Fast-paced Momentum, Bionano Genomics (BNGO) Is Still a Bargain Stock - Yahoo Finance

Click here to get full coverage on HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BNGO) with Buy Recommendation - Nasdaq

HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BNGO) with Buy Recommendation  Nasdaq

HC Wainwright & Co. Initiates Coverage of Bionano Genomics (BNGO) with Buy Recommendation - Nasdaq

Click here to get full coverage on Earnings To Watch: Bionano Genomics Inc (BNGO) Reports Q3 2025 R - GuruFocus

Earnings To Watch: Bionano Genomics Inc (BNGO) Reports Q3 2025 R  GuruFocus

Earnings To Watch: Bionano Genomics Inc (BNGO) Reports Q3 2025 R - GuruFocus

Click here to get full coverage on Bionano Genomics (BNGO) Announces $10M Public Offering - GuruFocus

Bionano Genomics (BNGO) Announces $10M Public Offering  GuruFocus

Bionano Genomics (BNGO) Announces $10M Public Offering - GuruFocus

Click here to get full coverage on Bionano Genomics (BNGO) Is Attractively Priced Despite Fast-paced Momentum - Yahoo Finance

Bionano Genomics (BNGO) Is Attractively Priced Despite Fast-paced Momentum  Yahoo Finance

Bionano Genomics (BNGO) Is Attractively Priced Despite Fast-paced Momentum - Yahoo Finance

Click here to get full coverage on Bionano Genomics (NASDAQ: BNGO) reports OGM study in acute leukemia: 467 cases, 31.5% Tier 1 - Stock Titan

Bionano Genomics (NASDAQ: BNGO) reports OGM study in acute leukemia: 467 cases, 31.5% Tier 1  Stock Titan

Bionano Genomics (NASDAQ: BNGO) reports OGM study in acute leukemia: 467 cases, 31.5% Tier 1 - Stock Titan

Click here to get full coverage on Bionano Genomics Inc (BNGO) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges ... - Yahoo Finance

Bionano Genomics Inc (BNGO) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges ...  Yahoo Finance

Bionano Genomics Inc (BNGO) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges ... - Yahoo Finance

Click here to get full coverage on Analysts Are Upgrading Bionano Genomics, Inc. (NASDAQ:BNGO) After Its Latest Results - Yahoo Finance

Analysts Are Upgrading Bionano Genomics, Inc. (NASDAQ:BNGO) After Its Latest Results  Yahoo Finance

Analysts Are Upgrading Bionano Genomics, Inc. (NASDAQ:BNGO) After Its Latest Results - Yahoo Finance

Click here to get full coverage on Bionano Genomics Inc (BNGO) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges ... - Yahoo Finance

Bionano Genomics Inc (BNGO) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges ...  Yahoo Finance

Bionano Genomics Inc (BNGO) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges ... - Yahoo Finance

Click here to get full coverage on Maxim Group Upgrades Bionano Genomics (BNGO) - Nasdaq

Maxim Group Upgrades Bionano Genomics (BNGO)  Nasdaq

Maxim Group Upgrades Bionano Genomics (BNGO) - Nasdaq

Click here to get full coverage on Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2025 Earnings Call Transcript - Insider Monkey

Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2025 Earnings Call Transcript  Insider Monkey

Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2025 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on Bionano Genomics (BNGO) Upgraded to Buy as Future Prospects Brig - GuruFocus

Bionano Genomics (BNGO) Upgraded to Buy as Future Prospects Brig  GuruFocus

Bionano Genomics (BNGO) Upgraded to Buy as Future Prospects Brig - GuruFocus

Click here to get full coverage on Bionano’s Unique Genomics Tools Offer Promise—And Plenty Of Risk - Finimize

Bionano’s Unique Genomics Tools Offer Promise—And Plenty Of Risk  Finimize

Bionano’s Unique Genomics Tools Offer Promise—And Plenty Of Risk - Finimize

Click here to get full coverage on Bionano Genomics (BNGO) Gains Key CMS Payment Approval for Genetic Testing - GuruFocus

Bionano Genomics (BNGO) Gains Key CMS Payment Approval for Genetic Testing  GuruFocus

Bionano Genomics (BNGO) Gains Key CMS Payment Approval for Genetic Testing - GuruFocus

Click here to get full coverage on Bionano Genomics (BNGO) Announces $10 Million Public Offering - GuruFocus

Bionano Genomics (BNGO) Announces $10 Million Public Offering  GuruFocus

Bionano Genomics (BNGO) Announces $10 Million Public Offering - GuruFocus

Click here to get full coverage on Bionano Genomics Second Quarter 2025 Earnings: Beats Expectations - simplywall.st

Bionano Genomics Second Quarter 2025 Earnings: Beats Expectations  simplywall.st

Bionano Genomics Second Quarter 2025 Earnings: Beats Expectations - simplywall.st

Click here to get full coverage on A Piece Of The Puzzle Missing From Bionano Genomics, Inc.'s (NASDAQ:BNGO) 28% Share Price Climb - simplywall.st

A Piece Of The Puzzle Missing From Bionano Genomics, Inc.'s (NASDAQ:BNGO) 28% Share Price Climb  simplywall.st

A Piece Of The Puzzle Missing From Bionano Genomics, Inc.'s (NASDAQ:BNGO) 28% Share Price Climb - simplywall.st

Click here to get full coverage on BNGO stock touches 52-week low at $3.15 amid market challenges - Investing.com

BNGO stock touches 52-week low at $3.15 amid market challenges  Investing.com

BNGO stock touches 52-week low at $3.15 amid market challenges - Investing.com

Click here to get full coverage on Bionano Genomics stock price target raised to $11 from $10 at H.C. Wainwright - Investing.com

Bionano Genomics stock price target raised to $11 from $10 at H.C. Wainwright  Investing.com

Bionano Genomics stock price target raised to $11 from $10 at H.C. Wainwright - Investing.com

Click here to get full coverage on Bionano to Participate in the H.C. Wainwright @ Home Event - GlobeNewswire

Bionano to Participate in the H.C. Wainwright @ Home Event  GlobeNewswire

Bionano to Participate in the H.C. Wainwright @ Home Event - GlobeNewswire

Click here to get full coverage on Bionano Genomics (BNGO) Highlights Optical Genome Mapping in New Publication - GuruFocus

Bionano Genomics (BNGO) Highlights Optical Genome Mapping in New Publication  GuruFocus

Bionano Genomics (BNGO) Highlights Optical Genome Mapping in New Publication - GuruFocus

Click here to get full coverage on Weekly Recap: Will BNGO stock attract more institutional investors - 2025 Major Catalysts & Precise Swing Trade Entry Alerts - moha.gov.vn

Weekly Recap: Will BNGO stock attract more institutional investors - 2025 Major Catalysts & Precise Swing Trade Entry Alerts  moha.gov.vn

Weekly Recap: Will BNGO stock attract more institutional investors - 2025 Major Catalysts & Precise Swing Trade Entry Alerts - moha.gov.vn

Click here to get full coverage on Bionano Genomics Q3 2025 Financial Results - TradingView — Track All Markets

Bionano Genomics Q3 2025 Financial Results  TradingView — Track All Markets

Bionano Genomics Q3 2025 Financial Results - TradingView — Track All Markets

Click here to get full coverage on Bionano Genomics, Inc. (NASDAQ:BNGO) Q2 2025 Earnings Call Transcript - Insider Monkey

Bionano Genomics, Inc. (NASDAQ:BNGO) Q2 2025 Earnings Call Transcript  Insider Monkey

Bionano Genomics, Inc. (NASDAQ:BNGO) Q2 2025 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on Bionano Genomics closes $10 million public offering - Investing.com

Bionano Genomics closes $10 million public offering  Investing.com

Bionano Genomics closes $10 million public offering - Investing.com

Click here to get full coverage on Bionano Genomics Announces Major 1-for-60 Reverse Stock Split, Set for January 24 | BNGO Stock News - Stock Titan

Bionano Genomics Announces Major 1-for-60 Reverse Stock Split, Set for January 24 | BNGO Stock News  Stock Titan

Bionano Genomics Announces Major 1-for-60 Reverse Stock Split, Set for January 24 | BNGO Stock News - Stock Titan

Click here to get full coverage on BNGO - Bionano Genomics Inc Latest Stock News & Market Updates - Stock Titan

BNGO - Bionano Genomics Inc Latest Stock News & Market Updates  Stock Titan

BNGO - Bionano Genomics Inc Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Bionano Genomics slides after pricing $10M equity offering - MSN

Bionano Genomics slides after pricing $10M equity offering  MSN

Bionano Genomics slides after pricing $10M equity offering - MSN

Click here to get full coverage on BioNano Genomics Completes $9 Million Public Offering - TipRanks

BioNano Genomics Completes $9 Million Public Offering  TipRanks

BioNano Genomics Completes $9 Million Public Offering - TipRanks

Click here to get full coverage on Bionano jumps 6% on Q3 revenue beat, 2025 guidance range - MSN

Bionano jumps 6% on Q3 revenue beat, 2025 guidance range  MSN

Bionano jumps 6% on Q3 revenue beat, 2025 guidance range - MSN

Click here to get full coverage on Biggest stock movers Thursday: UNH, CSCO, NTES, FL, BABA, and more (LAZR:NASDAQ) - Seeking Alpha

Biggest stock movers Thursday: UNH, CSCO, NTES, FL, BABA, and more (LAZR:NASDAQ)  Seeking Alpha

Biggest stock movers Thursday: UNH, CSCO, NTES, FL, BABA, and more (LAZR:NASDAQ) - Seeking Alpha

Click here to get full coverage on 12 Best Fundamentally Strong Penny Stocks to Buy Right Now - Insider Monkey

12 Best Fundamentally Strong Penny Stocks to Buy Right Now  Insider Monkey

12 Best Fundamentally Strong Penny Stocks to Buy Right Now - Insider Monkey

Click here to get full coverage on Earnings call transcript: Bionano Genomics Q3 2025 sees 21% revenue growth - Investing.com

Earnings call transcript: Bionano Genomics Q3 2025 sees 21% revenue growth  Investing.com

Earnings call transcript: Bionano Genomics Q3 2025 sees 21% revenue growth - Investing.com

Click here to get full coverage on Bionano Genomics Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Bionano Genomics Second Quarter 2025 Earnings: Beats Expectations  Yahoo Finance

Bionano Genomics Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Click here to get full coverage on Bionano Laboratories Announces CMS Preliminary Payment Determination for Optical Genome Mapping CPT Code - Quiver Quantitative

Bionano Laboratories Announces CMS Preliminary Payment Determination for Optical Genome Mapping CPT Code  Quiver Quantitative

Bionano Laboratories Announces CMS Preliminary Payment Determination for Optical Genome Mapping CPT Code - Quiver Quantitative

Click here to get full coverage on Bionano Genomics Launches $10 Million Public Offering - Yahoo Finance

Bionano Genomics Launches $10 Million Public Offering  Yahoo Finance

Bionano Genomics Launches $10 Million Public Offering - Yahoo Finance

Click here to get full coverage on 4,755,265 Common Stock of Bionano Genomics, Inc. are subject to a Lock-Up Agreement Ending on 17-NOV-2025. - marketscreener.com

4,755,265 Common Stock of Bionano Genomics, Inc. are subject to a Lock-Up Agreement Ending on 17-NOV-2025.  marketscreener.com

4,755,265 Common Stock of Bionano Genomics, Inc. are subject to a Lock-Up Agreement Ending on 17-NOV-2025. - marketscreener.com

Click here to get full coverage on Bionano Genomics Q1 2025 Financial Results - TradingView — Track All Markets

Bionano Genomics Q1 2025 Financial Results  TradingView — Track All Markets

Bionano Genomics Q1 2025 Financial Results - TradingView — Track All Markets

Click here to get full coverage on Earnings Snapshot: Bionano Genomics sees Q4, FY25 revenue below analysts' consensus - MSN

Earnings Snapshot: Bionano Genomics sees Q4, FY25 revenue below analysts' consensus  MSN

Earnings Snapshot: Bionano Genomics sees Q4, FY25 revenue below analysts' consensus - MSN

Click here to get full coverage on Bionano Genomics stock hits 52-week low at $4.9 amid sharp decline - Investing.com

Bionano Genomics stock hits 52-week low at $4.9 amid sharp decline  Investing.com

Bionano Genomics stock hits 52-week low at $4.9 amid sharp decline - Investing.com

Click here to get full coverage on Bionano Genomics Inc expected to post a loss of $6.00 a share - Earnings Preview - TradingView — Track All Markets

Bionano Genomics Inc expected to post a loss of $6.00 a share - Earnings Preview  TradingView — Track All Markets

Bionano Genomics Inc expected to post a loss of $6.00 a share - Earnings Preview - TradingView — Track All Markets

Click here to get full coverage on Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025 - The Manila Times

Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025  The Manila Times

Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025 - The Manila Times

Click here to get full coverage on Bionano Genomics Inc reports results for the quarter ended December 31 - Earnings Summary - TradingView — Track All Markets

Bionano Genomics Inc reports results for the quarter ended December 31 - Earnings Summary  TradingView — Track All Markets

Bionano Genomics Inc reports results for the quarter ended December 31 - Earnings Summary - TradingView — Track All Markets

Click here to get full coverage on Dow Falls Over 100 Points; US Retail Sales Top Estimates - Benzinga

Dow Falls Over 100 Points; US Retail Sales Top Estimates  Benzinga

Dow Falls Over 100 Points; US Retail Sales Top Estimates - Benzinga

Click here to get full coverage on Bionano Genomics, Inc. Announces 1-for-60 Reverse Stock Split Effective January 24, 2025 - Nasdaq

Bionano Genomics, Inc. Announces 1-for-60 Reverse Stock Split Effective January 24, 2025  Nasdaq

Bionano Genomics, Inc. Announces 1-for-60 Reverse Stock Split Effective January 24, 2025 - Nasdaq

Click here to get full coverage on Earnings call transcript: Bionano Genomics Q1 2025 sees revenue drop, stock surges - Investing.com

Earnings call transcript: Bionano Genomics Q1 2025 sees revenue drop, stock surges  Investing.com

Earnings call transcript: Bionano Genomics Q1 2025 sees revenue drop, stock surges - Investing.com

Click here to get full coverage on Bionano Genomics Posts Q2 Margin Gain - Nasdaq

Bionano Genomics Posts Q2 Margin Gain  Nasdaq

Bionano Genomics Posts Q2 Margin Gain - Nasdaq

Click here to get full coverage on Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress - The Globe and Mail

Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress  The Globe and Mail

Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress - The Globe and Mail

Click here to get full coverage on Bionano Genomics Reports Strong Q3 2025 Results - TipRanks

Bionano Genomics Reports Strong Q3 2025 Results  TipRanks

Bionano Genomics Reports Strong Q3 2025 Results - TipRanks

Click here to get full coverage on Bionano Genomics Reports Q2 2025 Financial Results - TipRanks

Bionano Genomics Reports Q2 2025 Financial Results  TipRanks

Bionano Genomics Reports Q2 2025 Financial Results - TipRanks

Click here to get full coverage on Bionano Genomics Reports Strong Q3 Earnings Amid Challenges - TipRanks

Bionano Genomics Reports Strong Q3 Earnings Amid Challenges  TipRanks

Bionano Genomics Reports Strong Q3 Earnings Amid Challenges - TipRanks

Click here to get full coverage on Bears are Losing Control Over Bionano Genomics (BNGO), Here's Why It's a 'Buy' Now - Yahoo Finance

Bears are Losing Control Over Bionano Genomics (BNGO), Here's Why It's a 'Buy' Now  Yahoo Finance

Bears are Losing Control Over Bionano Genomics (BNGO), Here's Why It's a 'Buy' Now - Yahoo Finance

Click here to get full coverage on Bionano Genomics Q2 2025 Earnings Preview - MSN

Bionano Genomics Q2 2025 Earnings Preview  MSN

Bionano Genomics Q2 2025 Earnings Preview - MSN

Click here to get full coverage on Bionano Genomics at H.C. Wainwright Event: Mapping the Future of Genomics - Investing.com

Bionano Genomics at H.C. Wainwright Event: Mapping the Future of Genomics  Investing.com

Bionano Genomics at H.C. Wainwright Event: Mapping the Future of Genomics - Investing.com

Click here to get full coverage on Bionano Genomics’ Earnings Call: Cautious Optimism Amid Challenges - TipRanks

Bionano Genomics’ Earnings Call: Cautious Optimism Amid Challenges  TipRanks

Bionano Genomics’ Earnings Call: Cautious Optimism Amid Challenges - TipRanks

Click here to get full coverage on Bionano Genomics Cuts Costs And Rises Above Expectations - Finimize

Bionano Genomics Cuts Costs And Rises Above Expectations  Finimize

Bionano Genomics Cuts Costs And Rises Above Expectations - Finimize

Click here to get full coverage on Transcript : Bionano Genomics, Inc., Q3 2025 Earnings Call, Nov 13, 2025 - marketscreener.com

Transcript : Bionano Genomics, Inc., Q3 2025 Earnings Call, Nov 13, 2025  marketscreener.com

Transcript : Bionano Genomics, Inc., Q3 2025 Earnings Call, Nov 13, 2025 - marketscreener.com

Click here to get full coverage on BioNano Genomics Announces $10 Million Direct Offering - Yahoo Finance

BioNano Genomics Announces $10 Million Direct Offering  Yahoo Finance

BNGO

Price Chart

Key Statistics

Technicals

About BNGO

Latest News

HC Wainwright & Co. Maintains Bionano Genomics (BNGO) Buy Recommendation - Nasdaq

Bionano Genomics (BNGO) Showcases Optical Genome Mapping Advances at AMP 2025 - GuruFocus

Bionano Genomics Inc (BNGO) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Cost ... - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers